Eperezolid | Interleukin Related interleukin-related.com

Product Name :
Eperezolid

Search keywords :
Eperezolid

drugId :
null

Target Vo:
50S ribosomal subunit

Target Vo Short Name :
50S ribosomal subunit

Moa_Name:
50S ribosomal subunit inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Gram-Positive Bacterial Infections

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Vedolizumab In Vivo
Anti-Mouse CD209b Antibody (22D1) Epigenetics
JNK2 Antibody: JNK2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46/54 kDa, targeting to JNK2. It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts